文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

载冬凌草甲素纳米结构脂质载体的制备及特性研究——一种控制释放给药系统。

Preparation and characteristics of oridonin-loaded nanostructured lipid carriers as a controlled-release delivery system.

机构信息

Department of Pharmaceutics, College of Pharmacy, Shandong University, Jinan, PR China.

出版信息

J Microencapsul. 2010 May;27(3):234-41. doi: 10.3109/02652040903079526.


DOI:10.3109/02652040903079526
PMID:20113167
Abstract

In order to improve drug entrapment efficiency and loading capacity, nanostructured lipid carriers consisting of solid lipid and liquid lipid as a new type of colloidal drug delivery system were prepared. The dispersions of oridonin-loaded solid lipid nanoparticles and nanostructured lipid carriers were successfully prepared by the emulsion-evaporation and low temperature-solidification technique using monostearin as the solid lipid, caprylic/capric triglycerides as the liquid lipid and oridonin as the model drug. Their physicochemical properties of oridonin-loaded nanostructured lipid carriers and release behaviours were investigated and compared with those of solid lipid nanoparticles. As a result, the mean particle size was approximately 200 nm with narrow polydispersity index lower than 0.4 for all developed formulations. Zeta potential values were in the range -35 mV approximately -50 mV, providing good physical stability of all formulations. The differential scanning calorimetry and X-ray diffraction analysis results demonstrated lipid nanoparticles exhibited crystal order disturbance and thus left more space to accommodate drug molecules. The improved drug entrapment efficiency and loading capacity were observed for nanostructured lipid carriers and they enhanced with increasing the caprylic/capric triglycerides content. In vitro drug release experiments exhibited biphasic drug release patterns with burst release initially and prolonged release afterwards. These results indicated that nanostructured lipid carriers could potentially be exploited as a delivery system with improved drug entrapment efficiency and controlled drug release.

摘要

为了提高药物包封效率和载药量,采用固态脂质和液态脂质作为新型胶体药物传递系统的纳米结构脂质载体被制备。通过乳化蒸发和低温固化技术,以单硬脂酸甘油酯作为固态脂质、辛酸/癸酸三酸甘油酯作为液态脂质和冬凌草甲素作为模型药物,成功制备了冬凌草甲素固体脂质纳米粒和纳米结构脂质载体的分散体。考察并比较了载冬凌草甲素的纳米结构脂质载体的理化性质和释放行为与固体脂质纳米粒的差异。结果表明,所有制剂的平均粒径约为 200nm,多分散指数均低于 0.4。Zeta 电位值在-35mV 至-50mV 范围内,为所有制剂提供了良好的物理稳定性。差示扫描量热法和 X 射线衍射分析结果表明,脂质纳米粒表现出晶体有序性的紊乱,从而为药物分子提供了更多的容纳空间。纳米结构脂质载体的药物包封效率和载药量得到提高,且随着辛酸/癸酸三酸甘油酯含量的增加而增加。体外药物释放实验显示出双相药物释放模式,初始突释,随后持续释放。这些结果表明,纳米结构脂质载体有望作为一种药物包封效率提高和药物释放控制的新型给药系统。

相似文献

[1]
Preparation and characteristics of oridonin-loaded nanostructured lipid carriers as a controlled-release delivery system.

J Microencapsul. 2010-5

[2]
In vitro and in vivo evaluation of oridonin-loaded long circulating nanostructured lipid carriers.

Int J Biol Macromol. 2012-1-24

[3]
Preparation and characterization of silybin-loaded nanostructured lipid carriers.

Drug Deliv. 2009-11-26

[4]
Preparation and characteristics of monostearin nanostructured lipid carriers.

Int J Pharm. 2006-5-11

[5]
Preparation and characterization of stearic acid nanostructured lipid carriers by solvent diffusion method in an aqueous system.

Colloids Surf B Biointerfaces. 2005-11-10

[6]
Are nanostructured lipid carriers (NLCs) better than solid lipid nanoparticles (SLNs): development, characterizations and comparative evaluations of clotrimazole-loaded SLNs and NLCs?

Eur J Pharm Sci. 2012-6-1

[7]
Preparation and characterization of nanostructured lipid carriers loaded traditional Chinese medicine, zedoary turmeric oil.

Drug Dev Ind Pharm. 2010-7

[8]
Physicochemical characterization and in vivo bioluminescence imaging of nanostructured lipid carriers for targeting the brain: apomorphine as a model drug.

Nanotechnology. 2010-9-8

[9]
In vivo studies on the oridonin-loaded nanostructured lipid carriers.

Drug Deliv. 2012-8-28

[10]
[Preparation and in vitro characterization of apigemin-loaded nanostructured lipid carriers].

Zhong Yao Cai. 2011-6

引用本文的文献

[1]
Design of Clofazimine-Loaded Lipid Nanoparticles Using Smart Pharmaceutical Technology Approaches.

Pharmaceutics. 2025-7-2

[2]
Development of Rapidly Dissolving Microneedles Integrated with Valsartan-Loaded Nanoliposomes for Transdermal Drug Delivery: In Vitro and Ex Vivo Evaluation.

Pharmaceutics. 2025-4-7

[3]
Oridonin suppresses gastric cancer SGC-7901 cell proliferation by targeting the TNF-alpha/androgen receptor/TGF-beta signalling pathway axis.

J Cell Mol Med. 2023-9

[4]
Formulation Development and Investigations on Therapeutic Potential of Nanogel from L. Extract in Testosterone-Induced Alopecia.

Biomed Res Int. 2023

[5]
Curcumin Nanoparticles Enhance Antioxidant Efficacy of Diclofenac Sodium in Experimental Acute Inflammation.

Biomedicines. 2021-12-28

[6]
Transdermal Drug Delivery Systems and Their Use in Obesity Treatment.

Int J Mol Sci. 2021-11-25

[7]
Phytol-Loaded Solid Lipid Nanoparticles as a Novel Anticandidal Nanobiotechnological Approach.

Pharmaceutics. 2020-9-13

[8]
Solubility and Bioavailability Enhancement of Oridonin: A Review.

Molecules. 2020-1-14

[9]
Proniosomal gel-derived niosomes: an approach to sustain and improve the ocular delivery of brimonidine tartrate; formulation, in-vitro characterization, and in-vivo pharmacodynamic study.

Drug Deliv. 2019-12

[10]
The Impact of Variables on Particle Size of Solid Lipid Nanoparticles and Nanostructured Lipid Carriers; A Comparative Literature Review.

Adv Pharm Bull. 2016-6

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索